Abstract: . . .  Dauzat M; Bounameaux H; Janbon C; de Moerloose P. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet, 2002 Mar 2; 359 (9308): 747 -52. 21. Ifudu, O, Macey, LJ, Homel, P, Hyppolite, JC, Hong, J, Sumrani, N, Distant, D, Sonner, BG, Friedman, EA. Determinants of type of initial hemodialysis vascular access. Am J Nephrol, 1997 17(5): 425-427. Your questions, contributions and commentaries will be answered by the authors in the Clinical Cardiology list. Please fill in the form and press the "Send" button. Top Updating: 11/07/2003 Question, contribution or commentary : Name and Surname: : Country: : Argentina E-Mail address: @ Send Erase  . . .
. . .  Blom, HJ, Gerritis, WBJ, Rosendaal, FR, Haak, HL, Wijermans, PW, Bos, GMJ. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis ? Lancet. 1995; 345: 882-885. 15. Ridker, PM, Hennekens, CH, Selhub, J, Miletich, JP, Mlnow, MR, Stampfer, MJ. Interrelation of hyperhomocysteinemia, factor V Leiden, and risk of future venous thromboembolism. Circulation. 1997; 95: 1777-1782. 16. Sirrs, S, Duncan, L, Ognjenka, D, Nussbaumer, G, Ganz, G, Frohlich, J, Levin, A. Homocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship. Nephrol Dial Transplant 1999; 14: 738- 743. 17. Bowden, RG, Wyatt, F, Wilson, R. Homocysteine and Vascular Access Thrombosis in End-Stage Renal Disease Patients: A Retrospective Study. J Nephrol, 2003 (In Press). 18. Kes, P. Hyperhomocysteinemia in end-stage renal failure. Acta Med. Croat. 2000; 53(4-5): 175-181. 19. McCully, KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969; 56: 111-118. 20. Qur I; Perneger TV; Zittoun J; Bellet H; Gris JC; Daurs JP; Schved JF; Mercier E; Laroche JP; Dauzat M; Bounameaux H; Janbon C; de Moerloose P. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet, 2002 Mar 2; 359 (9308): 747 -52. 21. Ifudu, O, Macey, LJ, Homel, P, Hyppolite, . . .
--3000,2,750,2542,20424